BACKGROUND: Powassan virus (POWV) is a rarely diagnosed cause of encephalitis in the United States. In the Northeast, it is transmitted by Ixodes scapularis, the same vector that transmits Lyme disease. The prevalence of POWV among animal hosts and vectors has been increasing. We present 8 cases of POWV encephalitis from Massachusetts and New Hampshire in 2013-2015. METHODS: We abstracted clinical and epidemiological information for patients with POWV encephalitis diagnosed at 2 hospitals in Massachusetts from 2013 to 2015. We compared their brain imaging with those in published findings from Powassan and other viral encephalitides. RESULTS: The patients ranged in age from 21 to 82 years, were, for the most part, previously healthy, and presented with syndromes of fever, headache, and altered consciousness. Infections occurred from May to September and were often associated with known tick exposures. In all patients, cerebrospinal fluid analyses showed pleocytosis with elevated protein. In 7 of 8 patients, brain magnetic resonance imaging demonstrated deep foci of increased T2/fluid-attenuation inversion recovery signal intensity. CONCLUSIONS: We describe 8 cases of POWV encephalitis in Massachusetts and New Hampshire in 2013-2015. Prior to this, there had been only 2 cases of POWV encephalitis identified in Massachusetts. These cases may represent emergence of this virus in a region where its vector, I. scapularis, is known to be prevalent or may represent the emerging diagnosis of an underappreciated pathogen. We recommend testing for POWV in patients who present with encephalitis in the spring to fall in New England.
BACKGROUND:Powassan virus (POWV) is a rarely diagnosed cause of encephalitis in the United States. In the Northeast, it is transmitted by Ixodes scapularis, the same vector that transmits Lyme disease. The prevalence of POWV among animal hosts and vectors has been increasing. We present 8 cases of POWV encephalitis from Massachusetts and New Hampshire in 2013-2015. METHODS: We abstracted clinical and epidemiological information for patients with POWV encephalitis diagnosed at 2 hospitals in Massachusetts from 2013 to 2015. We compared their brain imaging with those in published findings from Powassan and other viral encephalitides. RESULTS: The patients ranged in age from 21 to 82 years, were, for the most part, previously healthy, and presented with syndromes of fever, headache, and altered consciousness. Infections occurred from May to September and were often associated with known tick exposures. In all patients, cerebrospinal fluid analyses showed pleocytosis with elevated protein. In 7 of 8 patients, brain magnetic resonance imaging demonstrated deep foci of increased T2/fluid-attenuation inversion recovery signal intensity. CONCLUSIONS: We describe 8 cases of POWV encephalitis in Massachusetts and New Hampshire in 2013-2015. Prior to this, there had been only 2 cases of POWV encephalitis identified in Massachusetts. These cases may represent emergence of this virus in a region where its vector, I. scapularis, is known to be prevalent or may represent the emerging diagnosis of an underappreciated pathogen. We recommend testing for POWV in patients who present with encephalitis in the spring to fall in New England.
Authors: Michael Haley; Avi S Retter; Daniel Fowler; Jaun Gea-Banacloche; Naomi P O'Grady Journal: Clin Infect Dis Date: 2003-08-27 Impact factor: 9.079
Authors: Matthew T Aliota; Alan P Dupuis; Michael P Wilczek; Ryan J Peters; Richard S Ostfeld; Laura D Kramer Journal: Vector Borne Zoonotic Dis Date: 2014-04-01 Impact factor: 2.133
Authors: Elisabeth R Krow-Lucal; Nicole P Lindsey; Marc Fischer; Susan L Hills Journal: Vector Borne Zoonotic Dis Date: 2018-03-13 Impact factor: 2.133
Authors: Isaac H Solomon; Kristyn M Spera; Sophia L Ryan; Jeffrey Helgager; Juliana Andrici; Sherif R Zaki; Henrikas Vaitkevicius; Kristoffer E Leon; Michael R Wilson; Joseph L DeRisi; Sophia Koo; Stelios M Smirnakis; Umberto De Girolami Journal: JAMA Neurol Date: 2018-06-01 Impact factor: 18.302
Authors: Derek J Platt; Amber M Smith; Nitin Arora; Michael S Diamond; Carolyn B Coyne; Jonathan J Miner Journal: Sci Transl Med Date: 2018-01-31 Impact factor: 17.956